-
A Good Run
After 13 and a half years, the intersection of science and business remains a compelling subject, but there are other things I now want to do, and it’s time to bring Science & Enterprise to a close.
-
Nanotech Pancreatic Cancer Immunotherapy Gains FDA Fast Track
The developer of an experimental immunotherapy delivering nanoscale payloads to treat pancreatic cancer says the treatment received fast-track status from the Food and Drug Administration.
-
Biotech, Academic Labs Partner on Ultrasound Brain Therapy
A developer of treatments for brain disorders and researchers at Stanford University aim to harness ultrasound to deliver drugs in nanoscale particles to precise regions of the brain.
-
Trial Okayed for Gene-Edited Stem Cell Lupus Treatment
A developer of treatments for cancer and autoimmune disorders from stem cells says FDA cleared its request to start a clinical trial of its therapy for systemic lupus erythematosus.
-
DNA Data Company Creates Portable Storage Media
A company developing DNA into a feasible method for large-scale data storage unveiled a credit card-sized device using DNA for off-line data storage.
-
Partnership to Discover Mental Health Peptides in Milk
A collaboration between biotechnology and dairy products businesses seeks to identify peptides in milk to form into dietary supplements for people with mood disorders.
-
Study to Provide Real World Data for A.I. Seizure Forecasts
A developer of medical monitoring systems with data from wearable devices will soon start asking individuals with epilepsy to offer data for an algorithm that predicts seizures.
-
$101M Challenge Seeks Healthy Aging Solutions
A new challenge competition from XPrize calls for proactive and accessible health care solutions for improving the quality of life among older people worldwide.
-
Trial Set to Test Inhaled mRNA for Viral Infections
A developer of messenger RNA therapies for respiratory and rare diseases says it received clearance to begin a clinical trial in the U.K. for an inhaled treatment for viral lung conditions.
-
Vaccine Patch Shown Safe, Produces Measles/Rubella Antibodies
A vaccine delivered with a patch device is shown in a clinical trial to generate neutralizing antibodies against measles and rubella similar to conventional injections.